Autism spectrum disorder and attention-deficit/hyperactivity disorder in children with cerebral palsy: results from screening in a population-based group.


Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 06 08 2019
accepted: 03 01 2020
pubmed: 14 1 2020
medline: 1 12 2020
entrez: 14 1 2020
Statut: ppublish

Résumé

Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are more common in children with cerebral palsy (CP) than in the general population, but may still be underdiagnosed. This study aimed to estimate screen-positive ASD and ADHD in a population-based group of 264 school-aged children with CP born 1999-2006 from the CP register of western Sweden. Validated parent-completed questionnaires were used at a median age of 12 years 11 months (range 8-17 years). Three different scales were used to detect signs of ASD and ADHD, respectively. Response rate was 88% (232/264). In 19 children, all in the most disabled group, the screening procedure was not feasible due to too few questionnaire items completed, leaving 213 for analyses. One third (74/213) of the children screened positive for ASD and half of the children (106/213) for ADHD, which was about twice as often as ASD/ADHD diagnoses had been clinically identified. Children with intellectual disability, epilepsy and/or impaired speech ability more often screened positive for ASD as well as ADHD. Severe motor impairment was more frequently associated with screen-positive ASD, but not ADHD. Neither sex nor CP type was associated with screen-positive ASD/ADHD. In conclusion, school-aged children with CP very often screened positive for ASD and/or ADHD. The prevalence of ASD and ADHD is most likely underestimated in children with CP. These screening findings require further investigations.

Identifiants

pubmed: 31927764
doi: 10.1007/s00787-020-01471-1
pii: 10.1007/s00787-020-01471-1
pmc: PMC7595991
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1569-1579

Références

Acta Paediatr. 2014 Jun;103(6):618-24
pubmed: 24575788
Res Dev Disabil. 2011 Mar-Apr;32(2):462-9
pubmed: 21273041
J Child Psychol Psychiatry. 1999 Jul;40(5):791-9
pubmed: 10433412
Eur J Paediatr Neurol. 2018 Jan;22(1):102-112
pubmed: 29108712
Acta Paediatr. 2010 Sep;99(9):1337-43
pubmed: 20377538
J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):438-447
pubmed: 17420678
J Child Psychol Psychiatry. 2006 Feb;47(2):167-75
pubmed: 16423148
BMJ. 1996 Apr 27;312(7038):1065-9
pubmed: 8616413
Dev Med Child Neurol. 2011 Jun;53(6):516-21
pubmed: 21574988
Dev Med Child Neurol. 1996 Apr;38(4):297-313
pubmed: 8641535
Dev Med Child Neurol. 2010 Nov;52(11):1056-61
pubmed: 20497458
Dev Med Child Neurol. 2008 Oct;50(10):744-50
pubmed: 18834387
J Autism Dev Disord. 1999 Apr;29(2):129-41
pubmed: 10382133
J Autism Dev Disord. 1995 Apr;25(2):81-104
pubmed: 7559289
Arch Pediatr Adolesc Med. 2010 Feb;164(2):160-5
pubmed: 20124145
J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):168-79
pubmed: 11211365
Res Dev Disabil. 2013 Oct;34(10):3202-10
pubmed: 23891732
J Autism Dev Disord. 2012 Jul;42(7):1491-7
pubmed: 22048962
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Soc Psychiatry Psychiatr Epidemiol. 2012 May;47(5):763-9
pubmed: 21499807
Dev Med Child Neurol. 2003 Nov;45(11):724-30
pubmed: 14580127
J Child Psychol Psychiatry. 1980 Jul;21(3):221-9
pubmed: 7430288
Dev Med Child Neurol. 2006 Jun;48(6):417-23
pubmed: 16700930
Res Dev Disabil. 2012 Jul-Aug;33(4):1287-93
pubmed: 22502856
Eur J Paediatr Neurol. 2019 Jan;23(1):31-42
pubmed: 30446273
Dev Med Child Neurol. 2009 Apr;51(4):289-94
pubmed: 19335564
Acta Paediatr. 2019 Nov;108(11):2048-2055
pubmed: 31077607
Res Dev Disabil. 2010 Nov-Dec;31(6):1543-51
pubmed: 20634041
Dev Med Child Neurol. 2014 Jan;56(1):59-65
pubmed: 24117446
J Am Acad Child Adolesc Psychiatry. 2002 Nov;41(11):1369-75
pubmed: 12410080
Res Dev Disabil. 2011 Nov-Dec;32(6):2875-88
pubmed: 21664105
Dev Med Child Neurol. 2009 May;51(5):356-63
pubmed: 19388148
Dev Med Child Neurol. 2017 Jul;59(7):738-742
pubmed: 28439889

Auteurs

Magnus Påhlman (M)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. magnus.pahlman@gnc.gu.se.
Regional Rehabilitation Centre, Queen Silvia Children's Hospital, Gothenburg, Sweden. magnus.pahlman@gnc.gu.se.

Christopher Gillberg (C)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Elisabet Wentz (E)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Kate Himmelmann (K)

Regional Rehabilitation Centre, Queen Silvia Children's Hospital, Gothenburg, Sweden.
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH